CPT code 43245 is frequently used to bill therapeutic upper gastrointestinal endoscopy that includes treatment of gastric or duodenal narrowing. It is essential to have proper documentation and accurate code selection as claims often demand clear documentation of the location, severity, and therapeutic procedure that was carried out.
As this is not only a diagnostic procedure but also a therapeutic process. It will involve endoscopic intervention, in which payers are usually requiring detailed documentation to support the Gastroenterology medical necessity. In Gastroenterology medical billing, reporting accurately will help minimize denials and ensure proper reimbursement for therapeutic endoscopy services.
CPT 43245 Description
Official Definition:
"Esophagogastroduodenoscopy, flexible, transoral; with dilation of gastric/duodenal stricture(s) (e.g., balloon, bougie)."
CPT 43245 describes an upper gastrointestinal endoscopic procedure in which a flexible endoscope is advanced through the mouth to examine the esophagus, stomach, and duodenum. During the procedure, the physician identifies a narrowing within the stomach or duodenum and performs dilation using a balloon, bougie, or similar device to improve luminal patency.
The procedure is commonly performed to relieve symptoms caused by gastric outlet obstruction or other benign and malignant strictures. The diagnostic EGD component is included in the code and should not be reported separately.
The service includes
- Flexible transoral esophagogastroduodenoscopy (EGD)
- Examination of the upper gastrointestinal tract
- Identification of gastric or duodenal strictures
- Dilation using balloon, bougie, or similar devices
- Assessment of post-dilation results
However, CPT 43245 does not include
- Separate billing of the diagnostic EGD
- Esophageal dilation procedures
- Additional reporting for multiple gastric or duodenal strictures treated during the same session
- Unbundling of included endoscopic services
Clinical Indications for CPT 43245
CPT 43245 will be used when the symptoms or functional obstruction of the stomach or duodenum is due to a gastric or duodenal stricture. This is frequently performed to restore food flow and increase gastrointestinal function.
Typical indications include
- Gastric outlet obstruction
- Benign gastric strictures
- Duodenal strictures
- Narrowing due to peptic ulcer disease
- Post surgical scarring and stenosis.
- Chronic pancreatitis-associated obstruction
- Malignant gastric or duodenal narrowing
- Difficulty eating, nausea, or vomiting caused by obstruction
The procedure may also be performed when a stricture is identified during diagnostic endoscopy and immediate treatment is clinically indicated.
Medical Necessity Criteria for CPT 43245
The usual criteria to determine medical necessity are the presence of symptoms associated with a gastric or duodenal stricture, abnormal gastric emptying, or gastric or duodenal obstruction that necessitates endoscopic intervention. Documentation should include a description of the site of narrowing and how severe it is and why dilation is required.
Some factors that can support include:
- Symptomatic gastric outlet obstruction
- Persistent nausea or vomiting
- Difficulty tolerating oral intake
- Benign or malignant strictures
- Radiologic or endoscopic evidence of luminal narrowing
Reimbursement Insights for CPT 43245
The reimbursement for CPT 43245 is higher than for a diagnostic EGD alone and is deemed to be a therapeutic procedure. There is usually coverage for those with documentation of a gastric or duodenal (2nd part of the duodenum) stricture that is obstructing the passage of food.
Key reimbursement considerations
- Medicare and most commercial health insurance companies will cover this when medically necessary
- Reimbursement for therapeutic EGD is typically more than reimbursement for diagnostic EGD.
- Global period: 000 days
- Diagnostic EGD is bundled into CPT 43245
- Multiple gastric or duodenal strictures treated during the same session are reported as one unit
- Reimbursement varies based on payer, geographic region, and site of service
- Hospital Outpatient Departments (HODs) and ASCs may get reimbursed at different facility rates.
Applicable Modifiers for CPT 43245
Modifier selection depends on procedural circumstances and any additional services performed during the encounter. Proper documentation should support all modifier usage.
Common modifiers
- Modifier -22: Hospital Outpatient Departments (HODs) and ASCs may get reimbursed at different facility rates.
- Modifier -52: Used when the planned dilation service is partially reduced or not fully completed.
- Modifier -53: Used when the procedure is discontinued due to patient safety concerns, technical limitations, or clinical instability.
- Modifier -59 or X{EPSU}: Used when a separate and distinct procedure is performed and meets payer requirements for separate reporting.
- Modifier -74: May be reported in facility settings when the procedure is discontinued after anesthesia administration.
Important billing rule:
CPT 43245 should be reported as the comprehensive therapeutic service when gastric or duodenal dilation is performed. The diagnostic EGD should not be billed separately.
Documentation Requirements for CPT 43245
Thorough documentation is necessary to justify medical necessity and selection of the appropriate codes. The location of the stricture should be clearly identified in the procedure report and the dilation that was performed should be described.
Documentation should include
- Medical indication for dilation
- Symptoms associated with the stricture
- Gastric or duodenal location of the stricture
- Severity and characteristics of the narrowing
- Dilation method used (balloon, bougie, etc.)
- Size of the dilation device utilized
- Number of dilation attempts performed
- Post-dilation findings
- Any complications or procedural limitations
- Patient tolerance of the procedure
- Signed final procedure report
Example Clinical Scenarios
Scenario 1: Gastric Outlet Obstruction Due to Peptic Ulcer Disease
A 67-year-old patient complains of ongoing nausea, vomiting and inability to tolerate solid food. The gastroenterologist finds a benign pyloric stricture during upper endoscopy, which is associated with chronic peptic ulcer disease. Balloon dilation is used to open up the blockage.
→ Coding Outcome: CPT 43245
→ Rationale: Therapeutic dilation of a gastric stricture was performed during EGD.
Scenario 2: Duodenal Stricture Associated with Chronic Pancreatitis
A patient with a history of chronic pancreatitis undergoes upper endoscopy for worsening symptoms of gastric outlet obstruction. A duodenal stricture is identified and successfully dilated using an endoscopic balloon.
→ Coding Outcome: CPT 43245
→ The rationale for reporting CPT 43245 for EGD with dilation of a duodenal stricture is that it is considered a distinct procedure.
Scenario 3: Malignant Gastric Stricture Treatment
In gastric cancer, the narrowing comes progressively and reduces the oral intake. A gastric stricture can be identified and dilated during an endoscopy, which will help to improve gastric emptying and control symptoms.
→ Coding Outcome: CPT 43245
→ Rationale: Therapeutic dilatation of malignant gastric stricture performed.
Scenario 4: Procedure Discontinued Due to Technical Difficulty
Endoscopic dilation is performed on a patient with a severe duodenal stricture. The physician is unable to move the dilation device safely forward and/or is concerned about the safety of the procedure, so it is discontinued before completion.
→ Coding Outcome: CPT 43245-53
→ Rationale: The procedure did not complete due to technical limitations and patient safety concerns.
BillingFreedom Driving 97%+ First-Pass Claim Accuracy in GI Billing
We at BillingFreedom support gastroenterology practices in advanced endoscopy procedures with enhancing the accuracy and consistency of billing workflow. The success of clinical documentation and its ability to accurately reflect the procedure performed is a major factor in determining reimbursement in complex GI services, particularly when an operation it involves more detailed findings and technique-specific interventions.
While performing for gastroenterology medical billing services, we emphasis to minimize claim submission variability. It is possible through robust documentation review and coding validation. This ensures practices remain compliant and enhances the efficiency and accuracy of reimbursement for outpatient and hospital-based gastroenterology services.
Key Revenue Cycle Performance Metrics
BillingFreedom performance is measured by structured benchmarks to capture the overall billing efficiency and coding accuracy of GI workflows:
- A consistent 97%–99% First-pass Claim Acceptance rate, resulting in quicker payments.
- Preventable denial rate was kept below 1% thereby reducing avoidable loss of revenue
- 95+% accuracy in clean claim submission, which boosts the efficiency of payers' processing
- Internal coding validation accuracy sustained at 98%+, ensuring strong compliance and consistency
- A continuous documentation alignment process is working to minimize claim rework cycles and administrative burden.
This performance-based approach enables gastroenterology practices to achieve stable revenue performance and more accurately handle complex procedural billing.
For more details about our top Gastroenterology medical billing services, please don't hesitate to contact us by email at info@billingfreedom.com or call us at +1 (855) 415-3472.
It is our top priority to give you financial peace of mind!
Related ICD-10-CM Codes
ICD-10-CM Codes
C16.2 - Malignant neoplasm of body of stomach
C16.9 - Malignant neoplasm of stomach, unspecified
C7A.092 - Malignant carcinoid tumor of the stomach
C7A.094 - Malignant carcinoid tumor of the foregut, unspecified
D13.99 - Benign neoplasm of ill-defined sites within the digestive system
D3A.092 - Benign carcinoid tumor of the stomach
D3A.094 - Benign carcinoid tumor of the foregut, unspecified
F50.010 - Anorexia nervosa, restricting type, mild
F50.011 - Anorexia nervosa, restricting type, moderate
F50.012 - Anorexia nervosa, restricting type, severe
F50.013 - Anorexia nervosa, restricting type, extreme
F50.014 - Anorexia nervosa, restricting type, in remission
F50.019 - Anorexia nervosa, restricting type, unspecified
F50.020 - Anorexia nervosa, binge eating/purging type, mild
F50.021 - Anorexia nervosa, binge eating/purging type, moderate
F50.022 - Anorexia nervosa, binge eating/purging type, severe
F50.023 - Anorexia nervosa, binge eating/purging type, extreme
F50.024 - Anorexia nervosa, binge eating/purging type, in remission
F50.029 - Anorexia nervosa, binge eating/purging type, unspecified
F50.20 - Bulimia nervosa, unspecified
F50.21 - Bulimia nervosa, mild
F50.22 - Bulimia nervosa, moderate
F50.23 - Bulimia nervosa, severe
F50.24 - Bulimia nervosa, extreme
F50.25 - Bulimia nervosa, in remission
F50.810 - Binge eating disorder, mild
F50.811 - Binge eating disorder, moderate
F50.812 - Binge eating disorder, severe
F50.813 - Binge eating disorder, extreme
F50.814 - Binge eating disorder, in remission
F50.819 - Binge eating disorder, unspecified
F50.83 - Pica in adults
F50.84 - Rumination disorder in adults
F98.21 - Rumination disorder of infancy and childhood
K20.0 - Eosinophilic esophagitis
K20.80 - Other esophagitis without bleeding
K20.81 - Other esophagitis with bleeding
K20.90 - Esophagitis, unspecified without bleeding
K20.91 - Esophagitis, unspecified with bleeding
K21.00 - Gastro-esophageal reflux disease with esophagitis, without bleeding
K21.01 - Gastro-esophageal reflux disease with esophagitis, with bleeding
K21.9 - Gastro-esophageal reflux disease without esophagitis
K22.0 - Achalasia of cardia
K22.10 - Ulcer of esophagus without bleeding
K22.70 - Barrett's esophagus without dysplasia
K22.710 - Barrett's esophagus with low grade dysplasia
K22.711 - Barrett's esophagus with high grade dysplasia
K22.719 - Barrett's esophagus with dysplasia, unspecified
K25.0 - Acute gastric ulcer with hemorrhage
K25.1 - Acute gastric ulcer with perforation
K25.2 - Acute gastric ulcer with both hemorrhage and perforation
K25.3 - Acute gastric ulcer without hemorrhage or perforation
K25.4 - Chronic or unspecified gastric ulcer with hemorrhage
K25.5 - Chronic or unspecified gastric ulcer with perforation
K25.6 - Chronic or unspecified gastric ulcer with both hemorrhage and perforation
K25.7 - Chronic gastric ulcer without hemorrhage or perforation
K25.9 - Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation
K27.0 - Acute peptic ulcer, site unspecified, with hemorrhage
K27.1 - Acute peptic ulcer, site unspecified, with perforation
K27.2 - Acute peptic ulcer, site unspecified, with both hemorrhage and perforation
K27.3 - Acute peptic ulcer, site unspecified, without hemorrhage or perforation
K27.4 - Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage
K27.5 - Chronic or unspecified peptic ulcer, site unspecified, with perforation
K27.6 - Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation
K27.7 - Chronic peptic ulcer, site unspecified, without hemorrhage or perforation
K27.9 - Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
K29.00 - Acute gastritis without bleeding
K29.30 - Chronic superficial gastritis without bleeding
K29.60 - Other gastritis without bleeding
K31.1 - Adult hypertrophic pyloric stenosis
K31.2 - Hourglass stricture and stenosis of stomach
K31.3 - Pylorospasm, not elsewhere classified
K31.4 - Gastric diverticulum
K31.811 - Angiodysplasia of stomach and duodenum with bleeding
K31.819 - Angiodysplasia of stomach and duodenum without bleeding
K31.89 - Other diseases of stomach and duodenum
K52.81 - Eosinophilic gastritis or gastroenteritis
K56.600 - Partial intestinal obstruction, unspecified as to cause
K56.601 - Complete intestinal obstruction, unspecified as to cause
K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction
K59.89 - Other specified functional intestinal disorders
K92.2 - Gastrointestinal hemorrhage, unspecified
Q38.5 - Congenital malformations of palate, not elsewhere classified
Q39.5 - Congenital dilatation of esophagus
Q40.0 - Congenital hypertrophic pyloric stenosis
Q40.1 - Congenital hiatus hernia
Q40.2 - Other specified congenital malformations of stomach
Q40.3 - Congenital malformation of stomach, unspecified
Q40.8 - Other specified congenital malformations of upper alimentary tract
Q40.9 - Congenital malformation of upper alimentary tract, unspecified
Q45.8 - Other specified congenital malformations of digestive system
Q45.9 - Congenital malformation of digestive system, unspecified
Q85.82 - Other Cowden syndrome
Q85.83 - Von Hippel-Lindau syndrome
Q85.89 - Other phakomatoses, not elsewhere classified
R10.0 - Acute abdomen
R10.20 - Pelvic and perineal pain unspecified side
R10.21 - Pelvic and perineal pain right side
R10.22 - Pelvic and perineal pain left side
R10.23 - Pelvic and perineal pain bilateral
R10.24 - Suprapubic pain
R10.85 - Abdominal pain of multiple sites
R10.9 - Unspecified abdominal pain
R11.10 - Vomiting, unspecified
R11.14 - Bilious vomiting
R11.15 - Cyclical vomiting syndrome unrelated to migraine
R11.2 - Nausea with vomiting, unspecified
R93.3 - Abnormal findings on diagnostic imaging of other parts of digestive tract
T18.3XXD - Foreign body in small intestine, subsequent encounter
T18.3XXS - Foreign body in small intestine, sequela
T18.8XXD - Foreign body in other parts of alimentary tract, subsequent encounter
T18.9XXD - Foreign body of alimentary tract, part unspecified, subsequent encounter
T18.9XXS - Foreign body of alimentary tract, part unspecified, sequela
T54.1X1D - Toxic effect of other corrosive organic compounds, accidental (unintentional), subsequent encounter
T54.1X1S - Toxic effect of other corrosive organic compounds, accidental (unintentional), sequela
T54.1X2D - Toxic effect of other corrosive organic compounds, intentional self-harm, subsequent encounter
T54.1X2S - Toxic effect of other corrosive organic compounds, intentional self-harm, sequela
T54.1X3D - Toxic effect of other corrosive organic compounds, assault, subsequent encounter
T54.1X3S - Toxic effect of other corrosive organic compounds, assault, sequela
T54.1X4D - Toxic effect of other corrosive organic compounds, undetermined, subsequent encounter
T54.1X4S - Toxic effect of other corrosive organic compounds, undetermined, sequela
T54.2X1D - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), subsequent encounter
T54.2X1S - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), sequela
T54.2X2D - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, subsequent encounter
T54.2X2S - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, sequela
T54.2X3D - Toxic effect of corrosive acids and acid-like substances, assault, subsequent encounter
T54.2X3S - Toxic effect of corrosive acids and acid-like substances, assault, sequela
T54.2X4D - Toxic effect of corrosive acids and acid-like substances, undetermined, subsequent encounter
T54.2X4S - Toxic effect of corrosive acids and acid-like substances, undetermined, sequela
T54.3X1D - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), subsequent encounter
T54.3X1S - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), sequela
T54.3X2D - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, subsequent encounter
T54.3X2S - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela
T54.3X3D - Toxic effect of corrosive alkalis and alkali-like substances, assault, subsequent encounter
T54.3X3S - Toxic effect of corrosive alkalis and alkali-like substances, assault, sequela
T54.3X4D - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, subsequent encounter
T54.3X4S - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, sequela
T54.91XD - Toxic effect of unspecified corrosive substance, accidental (unintentional), subsequent encounter
T54.91XS - Toxic effect of unspecified corrosive substance, accidental (unintentional), sequela
T54.92XD - Toxic effect of unspecified corrosive substance, intentional self-harm, subsequent encounter
T54.92XS - Toxic effect of unspecified corrosive substance, intentional self-harm, sequela
T54.93XD - Toxic effect of unspecified corrosive substance, assault, subsequent encounter
T54.93XS - Toxic effect of unspecified corrosive substance, assault, sequela
T54.94XD - Toxic effect of unspecified corrosive substance, undetermined, subsequent encounter
T54.94XS - Toxic effect of unspecified corrosive substance, undetermined, sequela
T57.1X1D - Toxic effect of phosphorus and its compounds, accidental (unintentional), subsequent encounter
T57.1X1S - Toxic effect of phosphorus and its compounds, accidental (unintentional), sequela
T57.1X2D - Toxic effect of phosphorus and its compounds, intentional self-harm, subsequent encounter
T57.1X2S - Toxic effect of phosphorus and its compounds, intentional self-harm, sequela
T57.1X3D - Toxic effect of phosphorus and its compounds, assault, subsequent encounter
T57.1X3S - Toxic effect of phosphorus and its compounds, assault, sequela
T57.1X4D - Toxic effect of phosphorus and its compounds, undetermined, subsequent encounter
T57.1X4S - Toxic effect of phosphorus and its compounds, undetermined, sequela
T65.5X1D - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), subsequent encounter
T65.5X1S - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), sequela
T65.5X2D - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, subsequent encounter
T65.5X2S - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela
T65.5X3D - Toxic effect of nitroglycerin and other nitric acids and esters, assault, subsequent encounter
T65.5X3S - Toxic effect of nitroglycerin and other nitric acids and esters, assault, sequela
T65.5X4D - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, subsequent encounter
T65.5X4S - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, sequela
Z86.003 - Personal history of in-situ neoplasm of oral cavity, esophagus and stomach
Z86.004 - Personal history of in-situ neoplasm of other and unspecified digestive organs
Related CPT Codes
CPT Codes
43244 - Complete Billing & Coding Guide for EGD with Band Ligation of Esophageal and Gastric Varices
43248 - Complete Billing & Coding Guide for EGD with Guidewire-Assisted Esophageal Dilation
43249 - Complete Billing & Coding Guide for EGD With Esophageal Balloon Dilation
43251 - Complete Billing & Coding Guide for EGD With Snare Removal of Lesions
43254 - Complete Billing & Coding Guide for Endoscopic Mucosal Resection (EMR)
43255 - Complete Billing & Coding Guide for EGD With Control of Bleeding
43239 - Complete Billing & Coding Guide for EGD with Biopsy
43238 - Complete Billing & Coding Guide for EGD with EUS-Guided Fine Needle Aspiration
43236 - Complete Billing & Coding Guide for EGD with Directed Submucosal Injection